Shares of Pfizer Inc. (NYSE:PFE – Get Free Report) have received a consensus rating of “Moderate Buy” from the seventeen ...
Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.
By Bhanvi Satija and Patrick Wingrove (Reuters) -Johnson & Johnson has laid out plans to raise U.S. investments by 25% to ...
Andrew Baum, Pfizer's chief strategy and innovation officer, talked Thursday about the pharmaceutical company's drug ...
* Kroger (NYSE: KR) is working with its merchandising and sourcing teams to diversify the supplier base for some commodities in its fresh business, possibly shifting to geographies that will be less ...
(Reuters) - Johnson & Johnson plans to spend more than $55 billion to build four plants in the U.S. over the next four years, ...
Pfizer has officially kissed goodbye to its consumer health venture by selling its final 7.3% stake in Haleon for a tidy $3.3 ...
Amid rising risks, I favor high-yield stocks with strong business models. Check out the stock picks that offer stability, ...
Pfizer stock has delivered its long-term shareholders a dividend that has grown for 16 consecutive years. The pace of those ...
With Pfizer’s final stake sale in the bag, the two Big Pharma companies behind Haleon’s genesis have formally parted ways with the standalone consumer health giant. | After charting similar moves ...
VOV.VN - Pfizer Vietnam Company Limited (Pfizer VN) and Vietnam Vaccine Joint Stock Company (VNVC) signed a Memorandum of ...
In this article, we are going to take a look at where Pfizer Inc (NYSE:PFE) stands against other stocks that market experts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results